Moon Ho Leung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Moon Ho Leung has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Chak Sing Lau
Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
3 shared publications - Chi Chiu Mok
Tuen Mun Hospital
2 shared publications - Pui Shan Julia Chan
Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China
2 shared publications AnMarie Nguyen
SCAN Group, Long Beach, USA
1 shared publication- Brian Hon‐Yin Chung
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine and Queen Mary Hospital, The University of Hong Kong, 21 Sassoon Road, Hong Kong, China.
1 shared publication Carmen Tze Kwan Ho
Department of Medicine, Queen Mary Hospital , Hong Kong SAR, China
1 shared publication
Latest Publications
- 2 May 2023
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 63 (2) , 358-365
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry
To compare the incidence of major adverse cardiovascular events (MACEs), cancer and infective complications in rheumatoid arthritis (RA) patients using the JAK (JAKis) and TNF inhibitors (TNFis). A retrospective analysis of data from the Hong Kong Biologics Registry 2008–2021 was performed. RA patients who had ever used JAKis or TNFis were included. The incidence of MACEs, cancer and infections were compared between the two groups, with adjustment for confounding factors. A total of 2471 courses of JAKis (n = 551) and TNFis (N = 1920) were used in 1732 RA patients (83.7% women, age 53.8 ± 12.5 years; follow-up 6431 patient-years). JAKi users had significantly older age, more atherosclerotic risk factors and higher frequency of past malignancies. A total of 15 and 40 MACEs developed in the JAKi and TNFi users, respectively (incidence 1.34 vs 0.75 per 100 patient-years; p= 0.22). There was no significant difference in the incidence of cancers between the two groups (0.81 [JAKi] vs 0.85 [TNFi] per 100 patient-years; p= 0.25). The adjusted hazard ratios of MACE and cancer in the JAKi users were 1.36[0.62–2.96] (p= 0.44) and 0.87[0.39–1.95] (p= 0.74), respectively. Rates of infections were significantly higher in the JAKi than TNFi users (16.3 vs 9.9 per 100 patient-years; p= 0.02), particularly herpes zoster (3.49 vs 0.94 per 100 patient-years; p< 0.001). In a real-life setting, there is no increase in MACEs or cancers in users of the JAKis compared with the TNFis. However, the incidence of non-serious infections, including herpes zoster, was increased in users of the JAKis.
- 2 May 2023
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 63 (2) , 358-365
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry
To compare the incidence of major adverse cardiovascular events (MACEs), cancer and infective complications in rheumatoid arthritis (RA) patients using the JAK (JAKis) and TNF inhibitors (TNFis). A retrospective analysis of data from the Hong Kong Biologics Registry 2008–2021 was performed. RA patients who had ever used JAKis or TNFis were included. The incidence of MACEs, cancer and infections were compared between the two groups, with adjustment for confounding factors. A total of 2471 courses of JAKis (n = 551) and TNFis (N = 1920) were used in 1732 RA patients (83.7% women, age 53.8 ± 12.5 years; follow-up 6431 patient-years). JAKi users had significantly older age, more atherosclerotic risk factors and higher frequency of past malignancies. A total of 15 and 40 MACEs developed in the JAKi and TNFi users, respectively (incidence 1.34 vs 0.75 per 100 patient-years; p= 0.22). There was no significant difference in the incidence of cancers between the two groups (0.81 [JAKi] vs 0.85 [TNFi] per 100 patient-years; p= 0.25). The adjusted hazard ratios of MACE and cancer in the JAKi users were 1.36[0.62–2.96] (p= 0.44) and 0.87[0.39–1.95] (p= 0.74), respectively. Rates of infections were significantly higher in the JAKi than TNFi users (16.3 vs 9.9 per 100 patient-years; p= 0.02), particularly herpes zoster (3.49 vs 0.94 per 100 patient-years; p< 0.001). In a real-life setting, there is no increase in MACEs or cancers in users of the JAKis compared with the TNFis. However, the incidence of non-serious infections, including herpes zoster, was increased in users of the JAKis.
- Open Access
- 22 September 2022
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 38 (1) , 254-256
Association of Medicare Program Type with Healthcare Utilization Among People Experiencing Homelessness
- 22 September 2022
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 38 (1) , 254-256
Open AccessAssociation of Medicare Program Type with Healthcare Utilization Among People Experiencing Homelessness
- 1 August 2020
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 50 (4) , 749-758
Cumulative patient-based disease activity monitoring in rheumatoid arthritis – predicts sustained remission, flare and treatment escalation
- 1 August 2020
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 50 (4) , 749-758
Cumulative patient-based disease activity monitoring in rheumatoid arthritis – predicts sustained remission, flare and treatment escalation
- Open Access
- 21 May 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (10) , 3625
Sicca Symptoms, Oral Health Conditions, Salivary Flow and Oral Candida in Sjögren’s Syndrome Patients
This study aimed to investigate the relationships among sicca symptoms, oral health conditions, salivary profiles and oral Candida in Sjögren’s syndrome (SS) patients. Eighty-five SS patients (mean age = 50.5) and 40 healthy non-SS individuals (mean age = 51.4) were recruited. They self-completed the Sicca Symptoms Inventory (SSI). Decayed, missing and filled surface (DMFS) scores, salivary flow rates, pH and oral Candida colonization were determined. Mean SSI summary scores of SS patients and non-SS individuals were 11.1 and 5.4 respectively (p < 0.001). The most prevalent sicca symptoms in SS patients were eye irritation (93%), dry throat or nose (88%) and need of fluid for mouth wetting (88%). SS patients had significantly lower whole salivary flow rates than the non-SS individuals. Candida strains were isolated from over 60% of SS patients but not in non-SS patients. C. albicans was the predominant species. SSI summary score was negatively correlated to salivary flow rates while SSI summary and domain scores were positively correlated to the number of filled surfaces (FS) and DMFS scores and oral Candida counts. In conclusion, SS patients had more severe sicca symptoms than non-SS individuals. SSI scores were negatively correlated to the salivary flow rates but positively correlated to caries experience and oral Candida colonization.
- 21 May 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (10) , 3625
Open AccessSicca Symptoms, Oral Health Conditions, Salivary Flow and Oral Candida in Sjögren’s Syndrome Patients
This study aimed to investigate the relationships among sicca symptoms, oral health conditions, salivary profiles and oral Candida in Sjögren’s syndrome (SS) patients. Eighty-five SS patients (mean age = 50.5) and 40 healthy non-SS individuals (mean age = 51.4) were recruited. They self-completed the Sicca Symptoms Inventory (SSI). Decayed, missing and filled surface (DMFS) scores, salivary flow rates, pH and oral Candida colonization were determined. Mean SSI summary scores of SS patients and non-SS individuals were 11.1 and 5.4 respectively (p < 0.001). The most prevalent sicca symptoms in SS patients were eye irritation (93%), dry throat or nose (88%) and need of fluid for mouth wetting (88%). SS patients had significantly lower whole salivary flow rates than the non-SS individuals. Candida strains were isolated from over 60% of SS patients but not in non-SS patients. C. albicans was the predominant species. SSI summary score was negatively correlated to salivary flow rates while SSI summary and domain scores were positively correlated to the number of filled surfaces (FS) and DMFS scores and oral Candida counts. In conclusion, SS patients had more severe sicca symptoms than non-SS individuals. SSI scores were negatively correlated to the salivary flow rates but positively correlated to caries experience and oral Candida colonization.
- Open Access
- 7 May 2020
- Published by World Scientific Pub Co Pte Ltd in Journal of Clinical Rheumatology and Immunology
- Vol. 20 (01) , 9-20
Factors Associated with Renal Outcomes in an Inception Cohort of Biopsy-proven Lupus Nephritis Patients
- 7 May 2020
- Published by World Scientific Pub Co Pte Ltd in Journal of Clinical Rheumatology and Immunology
- Vol. 20 (01) , 9-20
Open AccessFactors Associated with Renal Outcomes in an Inception Cohort of Biopsy-proven Lupus Nephritis Patients
- 5 May 2019
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 58 (12) , 2229
Colchicine gastrotoxicity in a patient with chronic kidney disease
- 5 May 2019
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 58 (12) , 2229
Colchicine gastrotoxicity in a patient with chronic kidney disease
- Open Access
- 20 March 2017
- Published by Wiley in Case Reports in Medicine
- Vol. 2017, 1-3
A Case of Initially Undiagnosed Chikungunya Arthritis Developing into Chronic Phase in a Nonendemic Area
This case report described a 40-year-old lady presented with fever, headache, arthralgia, myalgia, and impaired liver function after returning from the Philippines. Chikungunya virus (CHIKV) and dengue serology were negative. Eight weeks after initial presentation, she experienced inflammatory polyarthritis mimic rheumatoid arthritis. This time CHIKV-IgM was detected, together with a >4-fold rise of CHIKV-polyvalent-antibody titre. The first CHIKV-IgM negative sample was reexamined and was CHIKV-PCR positive. CHIKV infection was confirmed and diagnosis of CHIKV-related arthritis was made. A quarter of CHIKV infected individuals develop post-CHIKV rheumatisms that affect quality of life and may need treatment with Disease Modifying Antirheumatic Drugs. This case highlights the importance of considering CHIKV infection in patients present with symmetrical polyarthritis particularly after travel to endemic regions. Testing of both CHIKV acute and convalescent-phase serum for CHIKV antibodies and PCR is recommended in suspicious case.
- 20 March 2017
- Published by Wiley in Case Reports in Medicine
- Vol. 2017, 1-3
Open AccessA Case of Initially Undiagnosed Chikungunya Arthritis Developing into Chronic Phase in a Nonendemic Area
This case report described a 40-year-old lady presented with fever, headache, arthralgia, myalgia, and impaired liver function after returning from the Philippines. Chikungunya virus (CHIKV) and dengue serology were negative. Eight weeks after initial presentation, she experienced inflammatory polyarthritis mimic rheumatoid arthritis. This time CHIKV-IgM was detected, together with a >4-fold rise of CHIKV-polyvalent-antibody titre. The first CHIKV-IgM negative sample was reexamined and was CHIKV-PCR positive. CHIKV infection was confirmed and diagnosis of CHIKV-related arthritis was made. A quarter of CHIKV infected individuals develop post-CHIKV rheumatisms that affect quality of life and may need treatment with Disease Modifying Antirheumatic Drugs. This case highlights the importance of considering CHIKV infection in patients present with symmetrical polyarthritis particularly after travel to endemic regions. Testing of both CHIKV acute and convalescent-phase serum for CHIKV antibodies and PCR is recommended in suspicious case.
- 31 July 2016
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 55 (11) , 1954-1958
Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease states and response criteria
Objective. Two versions of a patient-based DAS (PDAS) 1 and 2 (with and without ESR) have been developed and validated in RA. The objective of this study was to define PDAS1- and PDAS2-based criteria for remission, low, moderate and high disease activity and responses to treatment.
- 31 July 2016
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 55 (11) , 1954-1958
Defining criteria for rheumatoid arthritis patient-derived disease activity score that correspond to Disease Activity Score 28 and Clinical Disease Activity Index based disease states and response criteria
Objective. Two versions of a patient-based DAS (PDAS) 1 and 2 (with and without ESR) have been developed and validated in RA. The objective of this study was to define PDAS1- and PDAS2-based criteria for remission, low, moderate and high disease activity and responses to treatment.
- Open Access
- 26 April 2016
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2016 (4) , 91-93
Sequential occurrence of anti-glomerular basement membrane disease 9 years after anti-neutrophil cytoplasmic antibody-associated vasculitis
We report a case of 63-year-old Chinese man, having a history of anti-myeloperoxidase (MPO) antibody anti-neutrophil cytoplasmic antibody (ANCA)-associated pulmonary-renal syndrome 9 years ago, presented with second episode of rapidly progressive glomerulonephritis (RPGN) and alveolar haemorrhage compatible with anti-glomerular basement membrane (GBM) disease. In first presentation, his anti-GBM antibody was negative. This time, anti-MPO antibody was negative, but anti-GBM antibody was positive. The long interval of sequential development of anti-GBM disease after ANCA-associated vasculitis in this patient may provide clues to the potential immunological links between these two distinct conditions. Clinicians should be aware of such double-positive association.
- 26 April 2016
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2016 (4) , 91-93
Open AccessSequential occurrence of anti-glomerular basement membrane disease 9 years after anti-neutrophil cytoplasmic antibody-associated vasculitis
We report a case of 63-year-old Chinese man, having a history of anti-myeloperoxidase (MPO) antibody anti-neutrophil cytoplasmic antibody (ANCA)-associated pulmonary-renal syndrome 9 years ago, presented with second episode of rapidly progressive glomerulonephritis (RPGN) and alveolar haemorrhage compatible with anti-glomerular basement membrane (GBM) disease. In first presentation, his anti-GBM antibody was negative. This time, anti-MPO antibody was negative, but anti-GBM antibody was positive. The long interval of sequential development of anti-GBM disease after ANCA-associated vasculitis in this patient may provide clues to the potential immunological links between these two distinct conditions. Clinicians should be aware of such double-positive association.
- Open Access
- 20 March 2015
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 17 (1) , 67
Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus
- 20 March 2015
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 17 (1) , 67
Open AccessMeta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus